- Home
- BSX vs BME Comparison
BSX vs BME Comparison
Compare BSX & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- BME
- Stock Information
- Founded
- BSX 1979
- BME 2005
- Country
- BSX United States
- BME United States
- Employees
- BSX N/A
- BME N/A
- Industry
- BSX Medical/Dental Instruments
- BME Trusts Except Educational Religious and Charitable
- Sector
- BSX Health Care
- BME Finance
- Exchange
- BSX Nasdaq
- BME Nasdaq
- Market Cap
- BSX 138.4B
- BME 462.3M
- IPO Year
- BSX 1992
- BME N/A
- Fundamental
- Price
- BSX $107.04
- BME $36.35
- Analyst Decision
- BSX Strong Buy
- BME
- Analyst Count
- BSX 22
- BME 0
- Target Price
- BSX $112.86
- BME N/A
- AVG Volume (30 Days)
- BSX 7.9M
- BME 34.0K
- Earning Date
- BSX 07-23-2025
- BME 01-01-0001
- Dividend Yield
- BSX N/A
- BME 6.26%
- EPS Growth
- BSX 15.23
- BME N/A
- EPS
- BSX 1.37
- BME 1.44
- Revenue
- BSX $17,554,000,000.00
- BME N/A
- Revenue This Year
- BSX $17.50
- BME N/A
- Revenue Next Year
- BSX $10.75
- BME N/A
- P/E Ratio
- BSX $78.36
- BME $28.37
- Revenue Growth
- BSX 19.36
- BME N/A
- 52 Week Low
- BSX $71.88
- BME $35.53
- 52 Week High
- BSX $107.48
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- BSX 67.74
- BME 55.94
- Support Level
- BSX $100.90
- BME $35.30
- Resistance Level
- BSX $107.05
- BME $36.49
- Average True Range (ATR)
- BSX 1.56
- BME 0.37
- MACD
- BSX 0.64
- BME 0.05
- Stochastic Oscillator
- BSX 98.45
- BME 82.27
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.